Pocketcheck: Updating the HLA class I peptide specificity roadmap

Tissue Antigens

Volumn 80, Issue 3, 2012, Pages 239-248

  Huyton, T ^a   Ladas, N ^a   Schumacher, H ^a   Blasczyk, R ^a   Bade Doeding, C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Crystal structure; Histocompatibility; Peptide binding motif; Pockets; Polymorphism; Stem cell transplantation

Indexed keywords

AMINO ACID; HLA ANTIGEN CLASS 1; HLA B44 ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DATA BANK; X RAY CRYSTALLOGRAPHY;

ALLELES; AMINO ACID SEQUENCE; AMINO ACIDS; CELL LINE; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING;

EID: 84864794833     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01928.x     Document Type: Article

References (25)

1. Bade-Doding C, Theodossis A, Gras S et al. The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 2011: 96: 110-8.
2. Bade-Doeding C, DeLuca DS, Seltsam A, Blasczyk R, Eiz-Vesper B. Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants. Immunogenetics 2007: 59: 253-9.
3. Bade-Doeding C, Eiz-Vesper B, Figueiredo C, Seltsam A, Elsner HA, Blasczyk R. Peptide-binding motif of HLA-A*6603. Immunogenetics 2005: 56: 769-72.
4. Bade-Doeding C, Elsner HA, Eiz-Vesper B, Seltsam A, Holtkamp U, Blasczyk R. A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands. Immunogenetics 2004: 56: 83-8.
5. Bade-Doeding C, Huyton T, Eiz-Vesper B, Blasczyk R. The composition of the F pocket in HLA-A*74 generates C-terminal promiscuity among its bound peptides. Tissue Antigens 2011.
6. Elamin NE, Bade-Doeding C, Blasczyk R, Eiz-Vesper B. Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the POmega peptide motif. Tissue Antigens 2010: 76: 487-90.
7. Krausa P, Munz C, Keilholz W et al. Definition of peptide binding motifs amongst the HLA-A*30 allelic group. Tissue Antigens 2000: 56: 10-8.
8. Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W. Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics 1997: 45: 379-85.
9. Prilliman KR, Jackson KW, Lindsey M, Wang J, Crawford D, Hildebrand WH. HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol 1999: 162: 7277-84.
10. Prilliman KR, Lindsey M, Jackson KW, Cole J, Bonner R, Hildebrand WH. Complexity among constituents of the HLA-B*1501 peptide motif. Immunogenetics 1998: 48: 89-97.
11. Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989: 342: 692-6.
12. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991: 219: 277-319.
13. Chelvanayagam G. A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 1996: 45: 15-26.
14. Chothia C. The nature of the accessible and buried surfaces in proteins. J Mol Biol 1976: 105: 1-12.
15. Bade-Doeding C, Cano P, Huyton T et al. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P. Hum Immunol 2011: 72: 1039-44.
16. Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 1993: 9: 161-7.
17. Badrinath S, Saunders P, Huyton T et al. Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes. Haematologica 2012: 97: 98-106.
18. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997: 18: 2714-23.
19. Theodossis A, Guillonneau C, Welland A et al. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A 2010: 107: 5534-9.
20. DeLuca DS, Khattab B, Blasczyk R. A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics 2007: 59: 25-35.
21. Kotsch K, Blasczyk R. The noncoding regions of HLA-DRB uncover interlineage recombinations as a mechanism of HLA diversification. J Immunol 2000: 165: 5664-70.
22. Bade-Doeding C, Theodossis A, Gras S et al. The impact of human leucocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 2010.
23. Purcell AW, Gorman JJ, Garcia-Peydro M et al. Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol 2001: 166: 1016-27.
24. Badrinath S, Saunders P, Huyton T et al. Position 156 influences the peptide repertoire and tapasin dependency of human leucocyte antigen B*44 allotypes. Haematologica 2012: 97: 98-106.
25. Badrinath S, Huyton T, Schumacher H, Blasczyk R, Bade-Doeding C. Position 45 influences the peptide binding motif of HLA-B*44:08. Immunogenetics 2012: 64: 245-9.